Top Midday Gainers

MT Newswires Live

Yesterday

Corvus Pharmaceuticals (CRVS) said Tuesday that data from cohort 4 of a phase 1 trial of soquelitinib in severe atopic dermatitis showed favorable safety and efficacy results consistent with results from the first three cohorts.

Shares of the company more than doubled as intraday trading volume soared to over 48.7 million from a daily average of about 1.34 million.

GSK (GSK) said Tuesday it has agreed to acquire RAPT Therapeutics (RAPT) for an estimated equity value of $2.2 billion.

Shares of RAPT surged 63% as intraday trading volume soared to over 26.2 million from a daily average of roughly 455,000.

Citigroup raised its price target for the shares of Sandisk (SNDK) to $490 from $280 while maintaining the stock's buy rating.

Shares of Sandisk jumped 7.5%. Intraday trading volume stood at more than 11.4 million compared with a daily average of about 12.1 million.

Price: 18.23, Change: +10.18, Percent Change: +126.41

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2605148774"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605148774\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605148774?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 02:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605148774","market":"hk","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Corvus Pharmaceuticals (CRVS) said Tuesday that data from cohort 4 of a phase 1 trial of soquelitinib in severe atopic dermatitis showed favorable safety and efficacy results consistent with results from the first three cohorts.</p><p>Shares of the company more than doubled as intraday trading volume soared to over 48.7 million from a daily average of about 1.34 million.</p><p>GSK (GSK) said Tuesday it has agreed to acquire RAPT <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RAPT) for an estimated equity value of $2.2 billion.</p><p>Shares of RAPT surged 63% as intraday trading volume soared to over 26.2 million from a daily average of roughly 455,000.</p><p>Citigroup raised its price target for the shares of Sandisk (SNDK) to $490 from $280 while maintaining the stock's buy rating.</p><p>Shares of Sandisk jumped 7.5%. Intraday trading volume stood at more than 11.4 million compared with a daily average of about 12.1 million.</p><p>Price: 18.23, Change: +10.18, Percent Change: +126.41</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-21 02:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Corvus Pharmaceuticals (CRVS) said Tuesday that data from cohort 4 of a phase 1 trial of soquelitinib in severe atopic dermatitis showed favorable safety and efficacy results consistent with results from the first three cohorts.</p><p>Shares of the company more than doubled as intraday trading volume soared to over 48.7 million from a daily average of about 1.34 million.</p><p>GSK (GSK) said Tuesday it has agreed to acquire RAPT <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RAPT) for an estimated equity value of $2.2 billion.</p><p>Shares of RAPT surged 63% as intraday trading volume soared to over 26.2 million from a daily average of roughly 455,000.</p><p>Citigroup raised its price target for the shares of Sandisk (SNDK) to $490 from $280 while maintaining the stock's buy rating.</p><p>Shares of Sandisk jumped 7.5%. Intraday trading volume stood at more than 11.4 million compared with a daily average of about 12.1 million.</p><p>Price: 18.23, Change: +10.18, Percent Change: +126.41</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK.UK","symbol_name":"葛兰素史克","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2605148774","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605148774","pubTimestamp":1768932107,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Corvus Pharmaceuticals  said Tuesday that data from cohort 4 of a phase 1 trial of soquelitinib in severe atopic dermatitis showed favorable safety and efficacy results consistent with results from the first three cohorts.Shares of the company more than doubled as intraday trading volume soared to over 48.7 million from a daily average of about 1.34 million.GSK  said Tuesday it has agreed to acquire RAPT Therapeutics  for an estimated equity value of $2.2 billion.Shares of RAPT surged 63% as intraday trading volume soared to over 26.2 million from a daily average of roughly 455,000.Citigroup raised its price target for the shares of Sandisk  to $490 from $280 while maintaining the stock's buy rating.Shares of Sandisk jumped 7.5%. Intraday trading volume stood at more than 11.4 million compared with a daily average of about 12.1 million.Price: 18.23, Change: +10.18, Percent Change: +126.41","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GSK.UK":"葛兰素史克","BK4568":"美国抗疫概念","GSK":"葛兰素史克","RAPT":"RAPT Therapeutics, Inc.","CRVS":"Corvus Pharmaceuticals, Inc.","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU1829250122.USD":"高盛欧洲核心股票组合Acc","BK4532":"文艺复兴科技持仓","BK4139":"生物科技","BK4170":"电脑硬件、储存设备及电脑周边","BK4007":"制药"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK":1.87,"GSK.UK":0.6,"RAPT":1.94,"CRVS":1.95},"content_text":"Corvus Pharmaceuticals (CRVS) said Tuesday that data from cohort 4 of a phase 1 trial of soquelitinib in severe atopic dermatitis showed favorable safety and efficacy results consistent with results from the first three cohorts.Shares of the company more than doubled as intraday trading volume soared to over 48.7 million from a daily average of about 1.34 million.GSK (GSK) said Tuesday it has agreed to acquire RAPT Therapeutics (RAPT) for an estimated equity value of $2.2 billion.Shares of RAPT surged 63% as intraday trading volume soared to over 26.2 million from a daily average of roughly 455,000.Citigroup raised its price target for the shares of Sandisk (SNDK) to $490 from $280 while maintaining the stock's buy rating.Shares of Sandisk jumped 7.5%. Intraday trading volume stood at more than 11.4 million compared with a daily average of about 12.1 million.Price: 18.23, Change: +10.18, Percent Change: +126.41","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}